UNLABELLED: Very low birth weight (VLBW) infants, even those without bronchopulmonary dysplasia (BPD) are at risk for pulmonary morbidity during infancy. Although some studies have found an association between the level of neonatal oxygen exposure and later morbidity, others have not. A possible explanation for these inconsistent findings is that the cumulative dosage of neonatal supplemental oxygen to which infants are exposure is difficult to accurately quantify. METHODS: A prospective cohort study of VLBW infants without BPD was performed to test the hypothesis that cumulative oxygen exposure in the neonatal period summarized using an area under the curve analysis (Oxygen(AUC)) is predictive of later pulmonary symptoms. Risk factors tested in the analysis included both neonatal and outpatient respiratory exposures. Outcome measures included respiratory symptoms and use of medications and health services to treat those symptoms. RESULTS: The prevalence of pulmonary symptoms after NICU discharge was 48% (36 of 75 patients). Oxygen(AUC) as early as 72 hr of age predicts respiratory symptoms and respiratory-related health service and medication use during infancy in a dose dependent manner. Oxygen(AUC) is a stronger predictor of later respiratory symptoms than is the number of days of supplemental oxygen or positive pressure respiratory therapy or integrated mean airway pressure (MAP(AUC)). CONCLUSIONS: Oxygen(AUC) as early as 72 hr of age is predictive of later respiratory symptoms and use of health services and medications to treat those symptoms. Supplemental oxygen therapy should be monitored carefully to minimize oxygen exposure and risk of later respiratory symptoms in VLBW infants.
UNLABELLED: Very low birth weight (VLBW) infants, even those without bronchopulmonary dysplasia (BPD) are at risk for pulmonary morbidity during infancy. Although some studies have found an association between the level of neonatal oxygen exposure and later morbidity, others have not. A possible explanation for these inconsistent findings is that the cumulative dosage of neonatal supplemental oxygen to which infants are exposure is difficult to accurately quantify. METHODS: A prospective cohort study of VLBW infants without BPD was performed to test the hypothesis that cumulative oxygen exposure in the neonatal period summarized using an area under the curve analysis (Oxygen(AUC)) is predictive of later pulmonary symptoms. Risk factors tested in the analysis included both neonatal and outpatient respiratory exposures. Outcome measures included respiratory symptoms and use of medications and health services to treat those symptoms. RESULTS: The prevalence of pulmonary symptoms after NICU discharge was 48% (36 of 75 patients). Oxygen(AUC) as early as 72 hr of age predicts respiratory symptoms and respiratory-related health service and medication use during infancy in a dose dependent manner. Oxygen(AUC) is a stronger predictor of later respiratory symptoms than is the number of days of supplemental oxygen or positive pressure respiratory therapy or integrated mean airway pressure (MAP(AUC)). CONCLUSIONS:Oxygen(AUC) as early as 72 hr of age is predictive of later respiratory symptoms and use of health services and medications to treat those symptoms. Supplemental oxygen therapy should be monitored carefully to minimize oxygen exposure and risk of later respiratory symptoms in VLBW infants.
Authors: Bradley W Buczynski; Min Yee; B Paige Lawrence; Michael A O'Reilly Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-03-09 Impact factor: 5.464
Authors: Echezona T Maduekwe; Bradley W Buczynski; Min Yee; Tiruamalai Rangasamy; Timothy P Stevens; B Paige Lawrence; Michael A O'Reilly Journal: Pediatr Pulmonol Date: 2014-05-22
Authors: Katherine C Wai; Michael A Kohn; Roberta A Ballard; William E Truog; Dennis M Black; Jeanette M Asselin; Philip L Ballard; Elizabeth E Rogers; Roberta L Keller Journal: J Pediatr Date: 2016-07-26 Impact factor: 4.406
Authors: In Su Cheon; Young Min Son; Li Jiang; Nicholas P Goplen; Mark H Kaplan; Andrew H Limper; Hirohito Kita; Sophie Paczesny; Y S Prakash; Robert Tepper; Shawn K Ahlfeld; Jie Sun Journal: J Allergy Clin Immunol Date: 2017-12-15 Impact factor: 10.793
Authors: Kristin M Scheible; Jason Emo; Nathan Laniewski; Andrea M Baran; Derick R Peterson; Jeanne Holden-Wiltse; Sanjukta Bandyopadhyay; Andrew G Straw; Heidie Huyck; John M Ashton; Kelly Schooping Tripi; Karan Arul; Elizabeth Werner; Tanya Scalise; Deanna Maffett; Mary Caserta; Rita M Ryan; Anne Marie Reynolds; Clement L Ren; David J Topham; Thomas J Mariani; Gloria S Pryhuber Journal: JCI Insight Date: 2018-02-22
Authors: D C Neujahr; S D Perez; A Mohammed; O Ulukpo; E C Lawrence; F Fernandez; A Pickens; S D Force; M Song; C P Larsen; A D Kirk Journal: Am J Transplant Date: 2011-12-07 Impact factor: 8.086
Authors: Min Yee; R James White; Hani A Awad; Wendy A Bates; Sharon A McGrath-Morrow; Michael A O'Reilly Journal: Am J Pathol Date: 2011-05-06 Impact factor: 4.307
Authors: Ravi Misra; Syed Shah; Deborah Fowell; Hongyue Wang; Kristin Scheible; Sara Misra; Heidie Huyck; Claire Wyman; Rita M Ryan; Anne Marie Reynolds; Tom Mariani; Philip J Katzman; Gloria S Pryhuber Journal: Hum Immunol Date: 2015-03-20 Impact factor: 2.850